You are here

Article info

Article menu

Download PDFPDF

Autoimmunity
Review
CAR T cells for treating autoimmune diseases

Authors

  • Ulrich Blache Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, GermanyFraunhofer Cluster of Excellence for Immune-Mediated Disease, Leipzig, Germany PubMed articlesGoogle scholar articles
  • Sandy Tretbar Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, GermanyFraunhofer Cluster of Excellence for Immune-Mediated Disease, Leipzig, Germany PubMed articlesGoogle scholar articles
  • Ulrike Koehl Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, GermanyFraunhofer Cluster of Excellence for Immune-Mediated Disease, Leipzig, GermanyUniversity of Leipzig Faculty of Medicine, Leipzig, Germany PubMed articlesGoogle scholar articles
  • Dimitrios Mougiakakos University Hospital Magdeburg, Magdeburg, Germany PubMed articlesGoogle scholar articles
  • Stephan Fricke Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, GermanyFraunhofer Cluster of Excellence for Immune-Mediated Disease, Leipzig, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ulrich Blache; ulrich.blache{at}izi.fraunhofer.de
View Full Text

Citation

Blache U, Tretbar S, Koehl U, et al
CAR T cells for treating autoimmune diseases
RMD Open 2023;9:e002907. doi: 10.1136/rmdopen-2022-002907

Publication history

  • Received August 2, 2023
  • Accepted September 18, 2023
  • First published November 23, 2023.
Online issue publication 
February 14, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.